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Introduction
Primary  thyroid  lymphoma  is  a  relatively  rare  disease  of
the  thyroid  gland.  PTL  represents  approximately  1%--5%
of  thyroid  malignancies  and  less  than  2%  of  extra  nodal
lymphomas:  the  prognosis  is  generally  good.1 Thyroid  lym-
phomas  are  more  common  in  women  with  a  predominance
of  3--4:1.2
The  main  clinical  manifestation  is  a  rapidly  enlarging
thyroid  mass,  commonly  in  the  seventh  decade.  Approxi-
mately  30%--50%  of  patients  manifest  compression  symptoms
of  the  adjacent  structures,  in  addition  to  dysphagia,  stri-
dor,  hoarseness,  cough  and  a  pressure  sensation  in  the  neck.
Symptoms  such  as  fever,  night  sweats  and  weight  loss  are
less  common.  Hashimoto’s  thyroiditis  appears  to  be  a  risk
factor  for  thyroid  lymphoma  although  the  association  is  still
debated.1,2
The  most  common  histopathological  type  of  thyroid
lymphomas  is  non-Hodgkin’s  lymphoma  with  B  cell  origin.
Hodgkin’s  diseases  and  T-cell  lymphomas  are  rare  tumors.
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MALT)  lymphomas  tend  to  demonstrate  a  more  indolent
ourse  and  a  better  prognosis  compared  with  patients  with
iffuse  large  B-cell  types  or  mixed  histological  subtypes,
hich  may  have  a more  aggressive  clinical  course.3
A  general  5-year  survival  rate  for  PTL  is  approximately
0%;  therefore  a  well-planned  treatment  after  rapid  and
ccurate  diagnosis  generally  results  in  good  prognosis.4
ase report
 52-year-old-woman  was  admitted  to  the  otorhinolaryngo-
ogy  service  because  of  a  two-month  history  of  hoarseness
nd  left  otalgia.  No  breathing  or  swallowing  complaints  were
resent.  Prior  to  admission  to  our  clinic,  medical  treatment
ad  been  provided  for  her  twice  for  laryngitis,  but  her  com-
laints  did  not  improve.
She  reported  a  history  of  diabetes  mellitus,  hyperten-
ion  and  hypothyroidism  (chronic  lymphocytic  thyroiditis)
nd  also  cholecystectomy.
On physical  examination,  the  left  vocal  cord  was  ﬁxed
n  the  midline  and  fullness  on  left  false  vocal  cord  could
e  observed.  The  thyroid  lobes  demonstrated  nodules  bilat-
rally  and  were  enlarged,  with  the  left  lobe  being  slightly
rmer  and  larger  than  the  right.  There  were  no  cervical
alpable  masses  or  lymphadenopathy.
 Ce´rvico-Facial. Published by Elsevier Editora Ltda. This is an open
org/licenses/by-nc-nd/4.0/).
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Figure  3  Tumor  is  composed  of  atypical  lymphoid  cells,  which
have a  large  vesicular  nucleolus  and  signiﬁcant  nucleolus.  These
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pigure  1  Laryngeal  inﬁltration  with  cartilage  invasion  of  thy-
oid mass.
Thyroid  function  tests  were  within  normal  range  although
he  was  using  thyroid  hormones  for  hypothyroidism.  Thy-
oid  biopsy  had  been  performed  2  years  previously  and  the
istopathologic  report  revealed  a  chronic  lymphocytic  thy-
oiditis.
On  radiologic  evaluation  masses  in  the  left  false  vocal
ord  eroding  the  left  thyroid  cartilage,  continuous  with  the
hyroid  gland,  were  observed.  There  were  nodules  in  both
hyroid  lobes  (Fig.  1).
A  laryngeal  pathology  originating  from  the  left  laryngeal
tructures  that  eroded  thyroid  cartilage  and  extended  to  the
hyroid  gland  was  considered  after  examination.  A  direct
aryngoscopy  and  biopsy  procedure  from  both  left  laryngeal
entricles  and  a  ﬁne  needle  thyroid  biopsy  from  nodules  of
oth  thyroid  lobes  was  planned.
Biopsy  of  the  left  false  vocal  cord  was  reported  as  dif-
use  large  B  cell  lymphoma.  Fine  needle  aspiration  from
oth  thyroid  lobes  was  reported  as  atypical  lymphocytes
Figs.  2  and  3).  The  prognostic  factors  of  lymphoma  were
iagnosed  as  follows:  proliferative  index  of  Ki  67  was
0%--90%,  LDH  (lactate  dehydrogenase)  and  sedimentation
as  normal.  The  patient  reported  weight  loss  of  20  kg  in  the
igure  2  Diffuse  lymphoid  inﬁltrations  under  laryngeal
ucosa  (with  100×  magniﬁcation  on  pathologic  examination).
c
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eells have  positive  membranous  positivity  with  CD  20  marker
with 400×  magniﬁcation  on  pathologic  examination).
ast  4  months.  International  prognostic  index  (IPI)  score  was
ound  as  0.
A ﬂudeoxy  glucose-positron  emission  tomography  (FDG-
ET)  scan  for  differentiating  the  lesion  between  primary
hyroid  lymphoma  or  thyroid  involvement  of  a  systemic  dis-
ase  showed  only  diffuse  involvement  in  left  thyroid  lobe
Fig.  4).
As  a  result  of  these  diagnostic  tests  patient  was
iagnosed  as  diffuse  large  B  cell  primary  thyroid  lym-
homa,  stage  1E.  She  received  3  courses  of  R-CHOP
rituximab--cyclophosphamide,  doxorubicin,  vincristine  and
rednisolone)  treatment  and  involved-ﬁeld  radiation  ther-
py  following  chemotherapy.  Her  treatment  course  was
neventful  and  her  hoarseness  improved  after  treatment
Fig.  5).
A  team  including  oncology,  radiation  oncology,  oto-
hinolaryngology,  endocrinology  departments  followed  the
atient  every  month  after  chemoradiation  treatment.  She
ontinues  thyroid  replacement  treatment.  Her  thyroid  is
ow  grade  3  palpable  in  diffuse  and  hard  pattern.  There  can-
ot  be  identiﬁed  any  nodular  pattern  in  examination.  Both
igure  4  Thyroid  region,  which  is  only  involved  at  positron
mission  tomography--computed  tomography  evaluation.
Primary  thyroid  lymphoma  with  laryngeal  inﬁltration  
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rFigure  5  Neck  computed  tomography  after  treatment  shows
only minimally  laryngeal  edema,  without  any  mass  in  both  lar-
ynx and  thyroid  gland  (one  month  after  treatment).
vocal  cords  are  mobile  and  there  is  no  visible  pathologic
ﬁnding  in  laryngeal  evaluation.
Six  months  after  chemoradiation  therapy  the  patient  is
now  in  a  good  health  without  any  complaint.  Her  physical,
laboratory,  laryngeal  and  radiologic  evaluation  is  completely
normal  without  any  evidence  of  relapse  (Fig.  6).
Discussion
Extranodal  lymphomas  are  usually  seen  as  non-Hodgkin’s
lymphoma  (NHL)  which  constitute  10%--29%  of  all  lym-
phomas.  Adult  NHLs  commonly  arise  from  B  cells.  The
main  clinical  symptom  is  an  enlarging  mass  in  head  and
neck  region,  which  may  also  manifest  a  destructive  clinical
progress.
Extranodal  marginal  zone  B-cell  lymphoma  of  MALT  type
may  occur  in  the  stomach,  orbit,  intestine,  lung,  thyroid,
salivary  gland,  skin,  soft  tissues,  bladder,  kidney  and  central
nervous  system.  The  most  common  extranodal  extralym-
phatic  sites  are  the  paranasal  sinuses,  the  salivary  glands
and  the  thyroid  gland.4
Figure  6  Neck  computed  tomography  six  months  after  treat-
ment. Laryngeal  edema  has  decreased  a  little  more  over  time.
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The  larynx  is  a rare  site  for  localization  of  a  primary
HL  because  of  relatively  low  lymphoid  content.  In  the
iterature,  there  are  fewer  than  100  cases  of  lymphopro-
iferative  tumors  arising  from  the  larynx  (including  both
HL  and  immunosuppression-related  lymphoproliferative
iseases)  and  few  cases  of  laryngeal  inﬁltration  of  PTL  have
een  reported.  There  is  no  reported  case  of  PTL  presenting
ith  hoarseness  and  diagnosed  through  direct  laryngo-
copic  biopsy,  since  it  typically  does  not  erode  thyroid
artilage.
Primary  or  secondary  laryngeal  pathologies  may  manifest
imilar  symptoms  including  dysphonia,  hoarseness,  dyspha-
ia:  a  cervical  mass  can  be  found.  A  smooth  submucosal
welling  or  polypoid  mass  without  ulceration  are  the  usual
hysical  examination  ﬁndings  of  primary  laryngeal  lym-
homas.  Primary  laryngeal  lymphomas  usually  arise  from
he  supraglottic  region,  speciﬁcally  from  the  epiglottis  and
ryepiglottic  folds.5 Our  case  also  demonstrates  supraglottic
nﬁltration  especially  in  left  laryngeal  ventricule.  Extrala-
yngeal  tumor  extension  is  most  frequently  noted  to  involve
he  hypopharynx,  and  less  commonly  the  oropharynx  and
trap  muscles.
PTL  is  a  lymphamatous  process  which  develops  in  the
hyroid  without  involvement  of  primary  lymphoid  organs
r  distant  metastasis  at  the  time  of  diagnosis.  PTL  com-
rises  2%--8%  of  thyroid  malignancies.  It  is  mostly  seen  in
 middle-aged  elderly  women  with  a  median  age  of  56
ears.  Patients  usually  have  a  history  of  hypothyroidism
r  thyroiditis  and  mass  in  thyroid  gland  which  can  rapidly
row.  Dyspnea,  stridor,  dysphagia,  and  hoarseness  are  com-
on  symptoms  in  patients  with  thyroid  lymphoma,  while
ain  ﬁnding  may  only  be  an  enlarging  cervical  mass  which
resents  in  over  87%  of  patients.  However  PTL  may  suddenly
row  and  compromise  the  airway.
The  majority  of  PTLs  are  high  grade  while  only  30%  are
ow-grade.  Early  diagnosis  and  appropriate  treatment  of  thy-
oid  lymphomas  can  provide  long  time  survival.3
Anaplastic  thyroid  cancers  (ATC)  also  present  with  a
apidly  growing  large  mass  in  elderly  patients.  Anaplastic
hyroid  cancers,  which  compromise  1%--2%  of  thyroid  malig-
ancies,  have  similar  clinical  progress  and  must  be  included
n  the  differential  diagnosis  of  thyroid  lymphomas.  ATC’s
ay  rapidly  progress  and  compromise  the  air  way  with  an
verage  mean  survival  of  6--7  months.  On  radiologic  evalu-
tion  ATC  is  presents  as  a  large,  solid  mass  accompanied  by
ecrosis,  hemorrhage,  dense  calciﬁcation,  direct  invasion
f  adjacent  structures  and  cervical  lymph  node  metastasis.
umor  necrosis  has  been  known  to  be  one  of  the  most  valu-
ble  parameters  in  differentiating  ATC  from  other  thyroid
asses,  and  low  attenuation  value  on  post  contrast  scan
attenuation  value  <  100  HU)  is  another  predictor  of  anaplas-
ic  carninoma.6
Benign  or  malignant  thyroid  nodules  generally  grow
lowly  which  can  be  less  than  1  cm  over  38  months.
ompression  symptoms  due  to  acute  enlargement  of  thy-
oid  nodules  are  very  rare  and  may  result  in  life-threatening
omplications  like  acute  respiratory  compromise.  Sponta-
eous  hemorrhage  in  a  thyroid  nodule  or  a  malignant  process
uch  as  ATC  or  lymphomas  may  result  in  acute  enlargement.
PTL  patients  mostly  have  the  history  of  autoimmune  thy-
oiditis;  PTL  development  process  takes  an  average  of  20--30
ears  to  develop  after  the  onset  of  lymphocytic  thyroiditis.7
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Fine  needle  aspiration  with  or  without  ultrasonography
s  the  ﬁrst  step  in  diagnostic  strategy  for  a  thyroid  nodule,
ut  accuracy  is  quite  low  in  thyroid  lymphoma  or  anaplastic
ancer.  The  diagnostic  approaches  for  an  enlarging  thy-
oid  mass  are  FNA,  core  needle  biopsy  (CNB),  open  biopsy,
nd/or  surgical  intervention.  The  diagnostic  effect  of  FNA
dentiﬁes  30%--80%  of  thyroid  lymphoma  patients;  therefore
urther  diagnostic  approaches  may  be  useful  when  FNA  is
nconclusive.8 Core  needle  biopsy  (CNB)  generally  provides
nough  tissue  needed  for  the  certain  diagnosis  of  aggressive
hyroid  cancers  like  lymphoma  or  ATC.  Therefore  CNB  may
e  the  ﬁrst  diagnostic  step  when  a  large  aggressive  thyroid
ass  is  encountered  on  radiologic  evaluation.
Histological  and  phenotypic  analyses  such  as  ﬂow
ytology  or  immunohistochemistry  are  very  helpful  in  patho-
ogical  evaluation.  Most  thyroid  lymphomas  are  B-cell  origin
ith  diffuse  large-cell  type.
Most  patients  present  with  early  stages  IE  (30%--66%)  or
tage  IIE  (25%--66%)  disease.9 For  staging,  CT  scans  of  head,
eck,  chest,  abdomen  and  pelvis  or  FDG-PET  scan  should  be
erformed.
Treatment  options  consist  of  chemotherapy  alone,  radia-
ion  therapy  alone  and  combined  chemo-radiation  therapy.
lthough  there  are  some  articles  that  advise  thyroidec-
omy  followed  by  radiation  therapy,  the  series  reported
re  too  small  to  accept  as  widespread  use  as  a  treatment
ption.
The  overall  relapse  rates  are  7.7%,  37.1%  and  43%
or  chemoradiation  therapy,  radiation  therapy  alone,  and
hemotherapy  alone  respectively.  Local  relapse  rates  are
.6%,  12.6%  and  23%  for  chemoradiation  therapy,  radiation
herapy  alone,  and  chemotherapy  alone  respectively.1
The  most  common  chemotherapy  regimen  is  R-CHOP
rituximab--cyclophosphamide,  doxorubicin,  vincristine  and
rednisolone).  The  biologic  agent  rituximab,  a  monoclonal
ntibody  directed  against  B-cell-speciﬁc  antigen  CD  20  is
enerally  used  with  CHOP  chemotherapy  in  the  treatment
f  thyroid  lymphoma.
Radiotherapy  is  generally  chosen  after  3--6  CHOP  courses
n  the  form  of  modiﬁed  mantle  irradiation,  including  thyroid,
ilateral  neck,  supraclavicular  area  and  mediastinum.Age  (>60  years),  elevated  levels  of  serum  lactate  dehy-
rogenase  (LDH),  and  2 macroglobulin,  extra  nodal  site
nvolvement  and  stage  III--IV  classiﬁcation  are  poor  progno-
tic  factors.10
1Gökdog˘an  O  et  al.
Our  patient  received  R-CHOP  based  chemotherapy  and
adiotherapy  and  is  alive  without  any  sign  of  disease.
onclusion
he  present  report  details  the  ﬁrst  known  case  diagnosed
ith  thyroid  lymphoma  through  direct  laryngoscopy  and
iopsy.
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